Devyser Diagnostics Logo

Devyser Diagnostics

Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.

DVYSR | ST

Overview

Corporate Details

ISIN(s):
SE0016588867 (+1 more)
LEI:
549300RV4Z2K3360CK30
Country:
Sweden
Address:
Instrumentvägen 19, 126 53 Hägersten
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Devyser Diagnostics is a company specializing in the development, manufacture, and sale of advanced diagnostic kits for genetic DNA testing. Serving clinical laboratories, its product portfolio addresses critical areas such as reproductive health, oncology for guiding targeted cancer therapies, and post-transplant monitoring. Devyser's core mission is to simplify and streamline complex laboratory workflows by providing fast, accurate, and user-friendly solutions. The company's end-to-end tests are designed to significantly reduce sample-to-result times and manual handling, aiming to enhance laboratory efficiency, enable quicker patient diagnoses, and advance the accessibility of personalized medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Devyser Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Devyser Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Mia Arnhult Other Buy 7,000 745,290.00 SEK

Peer Companies

Company Country Ticker View
JEIL PHARMACEUTICAL CO.,LTD Logo
Global manufacturer of pharmaceutical APIs, antibiotics, and injection-based treatments.
South Korea 271980
JEIL PHARMA HOLDINGS INC. Logo
Develops and distributes APIs, generics, and modified drugs, specializing in injections.
South Korea 002620
JETEMA Co.,Ltd. Logo
Research-driven developer of aesthetic toxins, dermal fillers, and threads.
South Korea 216080
Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.
South Korea 007370
JW LIFESCIENCE CORPORATION Logo
A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.
South Korea 234080
JW SHINYAK CORPORATION Logo
Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.
South Korea 067290
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel KDST
kainos loboratories,inc Logo
Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.
Japan 4556
KAKEN PHARMACEUTIAL CO., LTD. Logo
R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.
Japan 4521
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel KMDA

Talk to a Data Expert

Have a question? We'll get back to you promptly.